Imidazoline Receptor

咪唑啉受体 (Imidazoline Receptor) 是可乐定和其他咪唑啉类药物作用的主要受体。咪唑啉受体有三类:I1 受体 - 介导咪唑啉类药物的交感神经抑制作用以降低血压(NISCH 或 IRAS,咪唑啉受体抗血清选择);I2 受体 - 单胺氧化酶的变构结合位点,参与疼痛调节和神经保护;I3 受体 - 调节胰腺 β 细胞的胰岛素分泌。激活的 I1-咪唑啉受体触发磷脂酰胆碱水解为 DAG。升高的 DAG 水平反过来会触发第二信使花生四烯酸和下游二十烷酸的合成。此外,钠氢反向转运体受到抑制,儿茶酚胺合成酶受到诱导。I1-咪唑啉受体可能属于神经细胞因子受体家族,因为其信号通路与白细胞介素相似。

Imidazoline receptors are the primary receptors on which clonidine and other imidazolines act. There are three classes of imidazoline receptors: I1 receptor – mediates the sympatho-inhibitory actions of imidazolines to lower blood pressure, (NISCH or IRAS, imidazoline receptor antisera selected), I2 receptor - an allosteric binding site of monoamine oxidase and is involved in pain modulation and neuroprotection, I3 receptor - regulates insulin secretion from pancreatic beta cells. Activated I1-imidazoline receptors trigger the hydrolysis of phosphatidylcholine into DAG. Elevated DAG levels in turn trigger the synthesis of second messengers arachidonic acid and downstreameicosanoids. In addition, the sodium-hydrogen antiporter is inhibited, and enzymes of catecholamine synthesis are induced. The I1-imidazoline receptor may belong to the neurocytokine receptorfamily, since its signaling pathways are similar to those of interleukins.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Aganodine

Aganodine 是一种可激活突触前咪唑啉受体的胍类化合物,能够抑制电诱发的 [3H]-去甲肾上腺素释放。

86696-87-9
Activator
Aganodine

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础